SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoins sharp rally is driving attention, with traders pointing to the Grayscale ETF filing and renewed interest in its proof-of-human identity use case amid growing AI-agent activity; some also cite Eightcos large WLD holdings as a source of institutional interest. Optimism about further gains and a potential short squeeze is tempered by skepticism over the tokens volatility and the fact that ETF approval remains uncertain.

Digital Turbine, Inc. engages in mobile growth platform solutions for advertisers, publishers, carriers, and device original equipment manufacturers. It operates through the following segments: On Device Solutions and App Growth Platform. The On Device Solutions segment consists of products and services that simplify the discovery and delivery of mobile apps and content media for device end users. The App Growth Platform segment provides Advertising Solutions and Ad Monetization Solutions. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbines volatile pullback and range-bound trading are driving discussion, with traders debating whether low-volume selling and options activity are weighing on shares or creating a buying opportunity ahead of earnings. Bullish investors point to improving growth and cash flow, while others remain concerned about dilution and the stocks weakness.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is drawing attention amid a high-volume rally and anticipation of founder Patrick Soon-Shiongs scheduled fireside chat, where investors are looking for trial updates. Traders also connect the broader NIH cancer-vaccine push to the companys investigational vaccine work; hopes for a partnership or short squeeze remain speculative.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

The FDAs acceptance of Intellias lonvo-z application for priority review has focused attention on its potential to bring a one-time gene-editing treatment for hereditary angioedema toward commercialization. Bulls see the regulatory milestone and Phase 3 results as validation, while skeptics point to financing and launch risks and question why the shares have reacted modestly.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

T-Mobile is drawing attention after SpaceXs spectrum deal intensified fears that Starlink Mobile could eventually compete with established wireless carriers, contributing to a sharp telecom selloff. Traders disagree on whether the threat warrants repricing now or is being overblown given the time, spectrum and ground infrastructure needed to build a rival network.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the following business segments: Consumer and Business. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

SpaceXs planned acquisition of low-band spectrum for Starlink Mobile has fueled a sharp selloff in Verizon shares amid concerns about future competition from a satellite-terrestrial wireless network. Traders are split between viewing the move as a serious long-term threat to Verizons customer base and seeing the selloff as an overreaction given the years and infrastructure needed to build a competitive network; some are also drawn to Verizons dividend and lower share price.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Long-term Treasury yields near multi-decade highs, amid inflation concerns tied partly to oil and expectations of a restrictive Fed, are weighing on TLT. Traders are split between expecting more downside as yields stay elevated and betting on a rebound or short squeeze after auction-related relief in yields.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound and repeated tests of resistance have fueled breakout talk, with bulls accumulating on dips while bears warn the move could fade. Traders also debate whether Chainlinks institutional and tokenization adoption will translate into lasting value for the LINK token.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinias planned early exit from its Rockville headquarters and procedural extensions in its generic-patent litigation have fueled speculation that a sale or further settlements may be approaching, though neither is confirmed. Traders welcomed the share-price rebound but debated whether it reflects company-specific developments or broader biotech-sector strength, with some expecting the gains to fade.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is under pressure after SpaceX agreed to acquire low-band spectrum for Starlink Mobile, heightening fears of long-term competition with established wireless carriers. Traders are divided between viewing the selloff as an overreaction given the time and infrastructure needed to build a rival network and seeing a meaningful future threat; many dip buyers point to AT&Ts dividend and existing business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IDEXX Laboratories to Release 2026 Third Quarter Financial Results

IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 third quarter financial results for Monday, November 2, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that...

Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories

Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX LaboratoriesPR NewswireCHICAGO, Sept. 30, 2026Transaction marks the first realization from the now...

Should You Continue to Hold IDXX Stock in Your Portfolio?

IDEXX's CAG growth, expanding software adoption and global gains face headwinds from FX and weaker U.S. vet visits.

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets...

IDEXX Stock Gains Following the Acquisition of CoVet

IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilities to improve veterinary workflows, diagnostics and practice performance.

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Faecal Dx antigen testing platform in the United Kingdom with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal...

IDEXX Buys CoVetAI To Expand Veterinary Workflow Intelligence

(RTTNews) - Veterinary diagnostics company IDEXX Laboratories, Inc. (IDXX) announced on Wednesday that it has acquired CoVetAI Inc., a provider of AI-native ambient listening and clinical workflow software for veterinary practices. Financial terms of the transaction were not disc...

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced the acquisition of CoVetAI Inc. (CoVet), a leading and rapidly growing provider of AI-native ambient listening and clinical workflow software for veterinary practices. Serving both multipractice...

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, and Andrew Emerson, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 24th...

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

Idexx Laboratories, Inc.

IDEXX Reports Upbeat Q1 Profit, Upgrades Full-Year Guidance: Retail’s Positive

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$518.00
Prev Close	$513.14
Open	$513.67
Dividend Yield	0.00%
50-Day Moving Average	$539.43
Beta	0.98
Avg. Volume	508,656.50
PE Ratio	36.41

52-Week High	$769.98
52-Week Low	$500.61
Market Capitalization	$40.43B
EPS (Annual)	$13.08
Price to Book	25.34
Revenue Per Employee	$391,245.64

Feed

News

Sentiment

Earnings

Fundamentals

Info

IDXX Fundamentals